| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |